tetano
Editor, Senior Moderator
Proc Natl Acad Sci U S A
. 2021 Nov 2;118(44):e2107148118.
doi: 10.1073/pnas.2107148118.
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
Lin Sun[SUP] 1 [/SUP], Somanath Kallolimath[SUP] 1 [/SUP], Roman Palt[SUP] 1 [/SUP], Karin Stiasny[SUP] 2 [/SUP], Patrick Mayrhofer[SUP] 3 [/SUP], Daniel Maresch[SUP] 4 [/SUP], Lukas Eidenberger[SUP] 1 [/SUP], Herta Steinkellner[SUP] 5 [/SUP]
Affiliations
Abstract
Here, we expressed two neutralizing monoclonal antibodies (Abs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; H4 and B38) in three formats: IgG1, IgA1 monomers (m), and IgA1 dimers (d) in glycoengineered Nicotiana benthamiana plants. All six Ab variants assembled properly and exhibited a largely homogeneous glycosylation profile. Despite modest variation in antigen binding between Ab formats, SARS-CoV-2 neutralization (NT) potency significantly increased in the following manner: IgG1 < IgA1-m < IgA1-d, with an up to 240-fold NT increase of dimers compared to corresponding monomers. Our results underscore that both IgA's structural features and multivalency positively impact NT potency. In addition, they emphasize the versatile use of plants for the rapid expression of complex human proteins.
Keywords: IgA; SARS-CoV-2; monoclonal antibodies; plant expression.
. 2021 Nov 2;118(44):e2107148118.
doi: 10.1073/pnas.2107148118.
Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
Lin Sun[SUP] 1 [/SUP], Somanath Kallolimath[SUP] 1 [/SUP], Roman Palt[SUP] 1 [/SUP], Karin Stiasny[SUP] 2 [/SUP], Patrick Mayrhofer[SUP] 3 [/SUP], Daniel Maresch[SUP] 4 [/SUP], Lukas Eidenberger[SUP] 1 [/SUP], Herta Steinkellner[SUP] 5 [/SUP]
Affiliations
- PMID: 34702738
- DOI: 10.1073/pnas.2107148118
Abstract
Here, we expressed two neutralizing monoclonal antibodies (Abs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; H4 and B38) in three formats: IgG1, IgA1 monomers (m), and IgA1 dimers (d) in glycoengineered Nicotiana benthamiana plants. All six Ab variants assembled properly and exhibited a largely homogeneous glycosylation profile. Despite modest variation in antigen binding between Ab formats, SARS-CoV-2 neutralization (NT) potency significantly increased in the following manner: IgG1 < IgA1-m < IgA1-d, with an up to 240-fold NT increase of dimers compared to corresponding monomers. Our results underscore that both IgA's structural features and multivalency positively impact NT potency. In addition, they emphasize the versatile use of plants for the rapid expression of complex human proteins.
Keywords: IgA; SARS-CoV-2; monoclonal antibodies; plant expression.